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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S339of patients with arthritis and in rodent models of arthritis. We found
that increasing MCP5 expression levels correlate with osteoarthritis
(OA) severity in a murine model of OA (destabilization of medial
meniscus, DMM). By using a Tgfbr2-b-Gal-GFP-BAC mouse, containing
b-gal and GFP reporters for TbRII expression, we have recently charac-
terized the TbRII expressing cells (TbRIIþ) as joint progenitors. Our
previous studies also demonstrated that intra-articular implants of
isolated TbRIIþ cells into DMM knees were able to abolish MCP-5 up-
regulation. Several studies have supported the hypothesis that TGF-b
and PTHrP act in a common signaling cascade to inhibit the develop-
ment of a calcifying phenotype in articular chondrocytes. Our studies
are aimed at determining whether blockade of MCP-5 signaling during
DMM affected OA progression and whether PTHrP could mediate such
signaling.
Methods. We followed two in-vivo approaches: 1) mice subjected to
DMM were treated with an antagonist of the MCP5 receptor CCR2
(RS504393 4mg/Kg/day in drinking water) 1 and 8weeks after DMM; 2)
FACS sorted TbRIIþ cells from Tgfbr2-b-Gal-GFP-BAC limb buds were
injected in the intra-articular space of DMM knees 1 and 8 weeks after
DMM (25X103 cells/15ml PBS) to inhibit MCP-5 expression in articular
cartilage. In both approaches, mice were euthanized 4 and 12-weeks
after DMM. Knees were subjected to micro-CT analysis followed by
decalciﬁcation and parafﬁn embedment for histological studies. Safra-
nin-O/Fast green staining was performed for OA grading following the
OARSI scoring system for mouse. Adjacent sections were subjected to
double-immunoﬂuorescence (IF) studies for TbRII and MCP-5 expres-
sions and in-situ hybridization (ISH) studies for PTHrP mRNA. In our in-
vitro approach, we isolated TbRIIþ cells and cultured them in micro-
mass condition with or without MCP-5 (20 ng/ml) for 3 days. cDNAwas
isolated and subjected to quantitative RT-PCR.
Results. TbRII expression is increased 2 weeks after DMM but its
expression is abolished by 4 weeks after surgery. TbRII decrease is
accompanied by increasing in MCP-5 expression (Fig.1). Inhibition of
MCP5 signaling by both approaches was able to decrease OA lesions
when RS504393 treatment or TbRIIþ cell implantswere performed at an
early stage of OAdevelopment, but not at later stages (Fig. 2). In a parallel
study conducted in our group we found that micro-CT analysis of DMM
posterior medial tibia show an increased mineralization of subchondral
bone compared to sham controls. We found that the subchondral bone
mineralization in the posterior medial tibia induced by DMM was
abolished when mice were treated with RS504393 at early stage com-
pared to untreated (Fig. 3). In our in-vitro approach we demonstrated
that MCP-5 has a direct inhibitory effect on PTHrP expression in TbRIIþ
joint progenitors (Fig.4). Consistently with TbRII expression pattern
during DMM, our in vivo studies show that PTHrP mRNA expression
levels in the periarticular chondrocytes increase at early stage of OA
development (2 week after surgery) but such regular expression is dis-
organized and decreased at later stages after DMM (Fig. 5).
Conclusions. Our ﬁndings show that progression of OA in early stage is
associated with derangement of TbRII-progenitors that leads to an
increase of MCP-5 and suggest that PTHrP might mediate MCP-5 effect
allowing articular chondrocytes to progress toward OA degeneration.
Our results open new perspective for OA treatment.593
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Purpose: Osteoarthritis (OA) is a highly prevalent disease in clinical
practice. It had been reported that various factors such as aging,
trauma and pro-inﬂammatory cytokines are involved in OA patho-
genesis. Oxidative stress is elevated in joint tissues including artic-
ular cartilage in aging and trauma, and it cause activating catabolic
factors such as inﬂammatory cytokines. Antioxidant enzymes such as
Heme oxygenase-1 (HO-1) are an important to prevent an accu-
mulation of oxidative stress, and play an important role in main-
tenance of cellular homeostasis. However, the role of HO-1 in OA
development remain unclear. Bach1 is a transcriptional repressor of
HO-1, thus Bach1-/- mice is upregulated HO-1 in various tissues. The
objective of this study was to deﬁne the function of HO-1 in OA
pathogenesis using Bach1-/- mice by two different animal models of
OA: an aging model, a surgical model.
Methods: To clarify the expression of HO-1 with aging, the knee
joints of newborn, 3, 12 and 22 month-old (m-o) wild-type mice
were assessed by immunohistochemistry using HO-1 antibody
(ab52947). To elucidate whether HO-1 involved in OA patho-
genesis, we used two different animal model of OA; an aging
models and a surgical models. As the aging model, we prepared 22
m-o Bach1-/- mice (n¼16, 22 knees) and wild-type mice (n¼8, 14
knees). Experimental OA was induced in 12 week-old (w-o)
Bach1-/- mice (n¼13) by transection of the medial meniscotibial
ligament and the medial collateral ligament in the right knees and
sacriﬁced 12 weeks later. Wild-type mice (n¼11) were used as a
control. Each knee was stained with Safranin O, and the modiﬁed
OARSI and Mankin’s scoring systems were used to validate the
histological changes of joint tissues. To deﬁne systemic inﬂam-
mation in Bach1-/- mice, the levels of proinﬂammatory cytokines
in serum were measured. Furthermore, to elucidate whether
reduction of OA severity in Bach1-/- mice associated with cellular
homeostasis, we examined LC-3, autophagy marker and the
expression of antioxidases such as SOD2 in knee joints by immu-
nohistochemistry, and also examined the relation between HO-1
and Autophagy or SOD2 in articular chondrocytes using HO-1
siRNA (siHO-1).
Results: The knee joints from wild-type mice at neonatal, 1 to 22
m-o showed an aging-related signiﬁcant reduction in HO-1 positive
cells. Whereas articular cartilage and meniscus in Bach1-/- mice
showed signiﬁcantly more HO-1 positive cells than 22 m-o wild-
type mice. Bach1-/- mice reduced the development of an age-
related OA-like pathology compared with the wild-type mice at 22
m-o. Histological scores indicated that Bach1-/- mice were sig-
niﬁcantly decreased in the severity of the OA-like changes. Bach1
-/- mice inhibited not only degradation of cartilage but also OA-like
changes of other joint tissues such as meniscus degeneration,
osteophyte formation and synovitis. In OA surgical model, Bach -/-
mice reduced the severity of OA-like changes than wild-type mice
as well as an aging model. In aged-mice (22 m-o), proinﬂammatory
cytokines in wild-type mice were signiﬁcantly increased compared
with that in young mice (10 w-o), however, these cytokines in
Bach1-/- mice did not signiﬁcantly change between young- and
aged-mice. In aged-mice, IL-1b, IL-2, IFNg and TNFa in Bach1-/-
mice were signiﬁcantly reduced compared with that in wild-type
mice. The number of LC3-positive chondrocytes in Bach1-/-
mice was signiﬁcantly higher than wild-type mice. SOD2
positive chondrocytes were also higher in Bach1-/- mice than wild-
type mice. Although the expression of SOD2 by siHO-1 was
reduced in Bach1-/- chondrocytes, LC-3 was not directly regulated
by HO-1.
Conclusions: Our present study showed that Bach1 -/- mice reduce the
severity of aging-related and experimental OA-like changes. The acti-
vation of autophagy and the expression of SOD2 were maintained in
articular cartilage of aged-Bach1 -/- mice. Thus, control of HO-1 might
be an effective treatment for OA prevention.
